Multiple Sclerosis
Conference Coverage
MS, DMTs, and pregnancy: Beware of over-caution regarding treatment
Don’t be too quick to stop therapy or too slow to restart it, researcher tells ECTRIMS audience.
Conference Coverage
Wearable devices show promise in monitoring multiple sclerosis
Further analysis may allow the prediction of “relevant changes throughout the course of multiple sclerosis.”
Conference Coverage
NMO: Study says double diagnoses with MS are common
Nearly half of patients with coding for NMO were also listed as having MS – a very similar condition.
Conference Coverage
EBV and MS: Just how deep is the link?
Two MS researchers disagree over how tightly they’re connected, and one says “second hit” may be factor.
Conference Coverage
Stem cell transplants in early MS: Who benefits most?
Neurologists outline findings as the MS field works toward consensus on HSCT as rescue therapy.
Conference Coverage
MS-tailored weight loss program achieves meaningful results
Weight loss “was associated with improved mobility, reduced fatigability, and improved physical quality of life.”
Conference Coverage
‘We’re halfway home’: UCSF’s Dr. Stephen Hauser sketches MS future
Identification of a reliable MS biomarker as well as early detection and intervention will be key going forward.
Conference Coverage
Next up in MS trials: More insight into progressive disease
Results from several treatment trials in progressive MS are expected over the next 2 years.
Conference Coverage
AI tool reveals MS drug interactions, offers safer options
Deep learning–based methods are “useful” in screening for potential interactions both between drugs and with foods.
Conference Coverage
Ocrelizumab benefit confirmed in older patients with MS
Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.
Conference Coverage
Obesity linked to multiple ills in MS study
Subjects with excess weight progressed more rapidly and had more cognitive disability.